Markus Maulhardt

5PUBLICATIONS
22CO-AUTHORS
Time-series analysisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 03, 2026
Epcoritamab in Richter Transformation: Insights from a Real-World Case Series.

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|Feb 03, 2026
Predicting adverse events for risk stratification of chemotherapy based stem cell mobilization in multiple myeloma.

F Schwarz, L Levien, M Maulhardt

|Aug 20, 2025
Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis.

Markus Maulhardt, Simon Call, Hristo Boyadzhiev

|Aug 14, 2025
Not All Weight Loss Is Equal: Divergent Patterns and Prognostic Roles in Head and Neck Cancer Versus High-Grade B-Cell Lymphoma.

Judith Büntzel, Gina Westhofen, Wilken Harms

Pageof 1

Frequent Collaborators

3 joint publications

Evgenii Shumilov

1 joint publications

F Schwarz

1 joint publications

L Levien

1 joint publications

E Aydilek